Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Cogan, Martin G.
Covey, Catherine M.
Arieff, Allen I.
Wisniewski, Amy
and
Clark, Orlo H.
1978.
Central nervous system manifestations of hyperparathyroidism.
The American Journal of Medicine,
Vol. 65,
Issue. 6,
p.
963.
Riley, Diana M.
and
Watt, David C.
1985.
Hypercalcemia in the etiology of puerperal psychosis.
Biological Psychiatry,
Vol. 20,
Issue. 5,
p.
479.
Borer, Marks S.
and
Bhanot, Veena K.
1985.
Hyperparathyroidism: Neuropsychiatric manifestations.
Psychosomatics,
Vol. 26,
Issue. 7,
p.
597.
Glen, A.I.M.
1985.
Lithium prophylaxis of recurrent affective disorders.
Journal of Affective Disorders,
Vol. 8,
Issue. 3,
p.
259.
Dubovsky, Steven L
1986.
Calcium Antagonists: A New Class of Psychiatric Drugs?.
Psychiatric Annals,
Vol. 16,
Issue. 12,
p.
724.
Dubovsky, Steven L.
Franks, Ronald D.
Allen, Stephen
and
Murphy, James
1986.
Calcium antagonists in mania: A double-blind study of verapamil.
Psychiatry Research,
Vol. 18,
Issue. 4,
p.
309.
Öztunç, Sueda
Guscott, Richard G.
Soni, Jorge
and
Steiner, Meir
1986.
Psychosis Resulting in Suicide in a Patient with Primary Hyperparathyroidism.
The Canadian Journal of Psychiatry,
Vol. 31,
Issue. 4,
p.
342.
Carlson, Richard J.
1986.
Longitudinal observations of two cases of organic anxiety syndrome.
Psychosomatics,
Vol. 27,
Issue. 7,
p.
529.
Linder, J.
Brismar, K.
Granberg, P.‐O.
Wetterberg, L.
and
Werner, S.
1988.
Characteristic changes in psychiatric symptoms, cortisol and melatonin but not prolactin in primary hyperparathyroidism.
Acta Psychiatrica Scandinavica,
Vol. 78,
Issue. 1,
p.
32.
Gennari, Carlo
1989.
New Actions of Parathyroid Hormone.
p.
335.
Arieff, A. I.
and
Fraser, C. L.
1990.
Acute Renal Failure in the Intensive Therapy Unit.
p.
255.
Malizia, Andrea L.
and
Bridges, Paul K.
1992.
The management of treatment-resistant affective disorder: clinical perspectives.
Journal of Psychopharmacology,
Vol. 6,
Issue. 2,
p.
145.
Bothwell, R. A.
Eccleston, D.
and
Marshall, E.
1994.
Platelet intracellular calcium in patients with recurrent affective disorders.
Psychopharmacology,
Vol. 114,
Issue. 2,
p.
375.
Brown, Thomas M.
and
Brown, Rebekah L.S.
1995.
Neuropsychiatric Consequences of Renal Failure.
Psychosomatics,
Vol. 36,
Issue. 3,
p.
244.
Mkrtchyan, Artur G.
Ghazaryan, Davit M.
Aghekyan, Elen R.
and
Israelyan, Narine R.
2022.
The role of calcium in the mechanisms of pathogenesis and pharmacotherapy of mental disorders: a brief review.
Armenian Journal of Health & Medical Sciences,
p.
24.
Harrison, Paul J.
Husain, Syed M.
Lee, Hami
Los Angeles, Alejandro De
Colbourne, Lucy
Mould, Arne
Hall, Nicola A.L.
Haerty, Wilfried
and
Tunbridge, Elizabeth M.
2022.
CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: Advances from functional genomics and pharmacoepidemiology.
Neuropharmacology,
Vol. 220,
Issue. ,
p.
109262.
Romanov, D.V.
Sheyanov, A.M.
Samsonova, M.D.
and
Iuzbashian, P.G.
2023.
Nimodipine in treatment of bipolar disorder.
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova,
Vol. 123,
Issue. 12,
p.
20.
Clapcote, S. J.
2024.
Drug Discovery for Schizophrenia.
p.
225.